Skip to main content
. 2015 Jul;10(7):1058–1060. doi: 10.4103/1673-5374.160079

Figure 1.

Figure 1

Bone marrow (BM)-derived cells for cell therapy of spinal cord injury (SCI).

(a) Sources of cells utilized for clinical cell therapy for SCI. (b) Study design and outcomes of preclinical and clinical studies demonstrating functional improvements when utilizing autologous bone marrow-derived cells (ABMCs) for cell therapy in the canine contusion model (Gabr et al., 2014) and phase I/II trial (NCT00816803) in chronic SCI patients (El-Kheir et al., 2014). GFP: Green fluorescent protein; ASIA impairment scale: The American Spinal Injury Association impairment scale.